Atlas Trials

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Various Formulations and Doses of PWT-143

Clinical trial NCT02521389 · COMPLETED

Trial details

NCT number
NCT02521389
Sponsor
MEI Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignancies
Start date
2015-06-29
Primary completion
2017-02-24
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.